Oxford BioMedica PLC Capital Reinvestment Ratio
Oxford BioMedica PLC capital reinvestment ratio. Oxford BioMedica PLC (OXB) has a Capital Reinvestment Ratio of 0.64x as of June 2025, meaning it reinvests 1% of its operating cash flow (GBX2.35 Million) in capital expenditures (GBX1.51 Million). See OXB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Oxford BioMedica PLC (2007–2021)
Capital reinvestment ratio of Oxford BioMedica PLC from 2007 to 2021. This chart tracks Oxford BioMedica PLC's Capital Reinvestment Ratio across 6 annual periods. See Oxford BioMedica PLC (OXB) flexibility index to measure the company's free cash flow as a share of total liabilities.
Oxford BioMedica PLC Capital Reinvestment Ratio by Year (2007–2021)
Oxford BioMedica PLC capital reinvestment ratio by year from 2007 to 2021. For the full cash flow conversion analysis, see OXB cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.37x | GBX25.45 Million | GBX9.46 Million | ▼ -91.3% |
| 2020 | 4.29x | GBX3.12 Million | GBX13.36 Million | ▲ +443.6% |
| 2018 | 0.79x | GBX12.87 Million | GBX10.15 Million | ▲ +19.3% |
| 2017 | 0.66x | GBX2.98 Million | GBX1.97 Million | ▲ +431.1% |
| 2009 | 0.12x | GBX2.31 Million | GBX288.00K | ▲ +39.8% |
| 2007 | 0.09x | GBX4.73 Million | GBX421.00K | — |